Centessa Pharmaceuticals Statistics

Total Valuation

CNTA has a market cap or net worth of $1.62 billion. The enterprise value is $1.41 billion.

Market Cap	1.62B
Enterprise Value	1.41B

Important Dates

The last earnings date was Tuesday, August 13, 2024, before market open.

Earnings Date	Aug 13, 2024
Ex-Dividend Date	n/a

Share Statistics

CNTA has 113.31 million shares outstanding. The number of shares has increased by 6.57% in one year.

Shares Outstanding	113.31M
Shares Change (YoY)	+6.57%
Shares Change (QoQ)	+9.61%
Owned by Insiders (%)	2.29%
Owned by Institutions (%)	45.18%
Float	65.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	210.75
Forward PS	n/a
PB Ratio	5.64
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	205.93
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.29, with a Debt / Equity ratio of 0.30.

Current Ratio	13.29
Quick Ratio	12.78
Debt / Equity	0.30
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-15.29

Financial Efficiency

Return on equity (ROE) is -55.84% and return on invested capital (ROIC) is -26.54%.

Return on Equity (ROE)	-55.84%
Return on Assets (ROA)	-24.54%
Return on Capital (ROIC)	-26.54%
Revenue Per Employee	$90,171
Profits Per Employee	-$2.07M
Employee Count	76
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	-496,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +107.25% in the last 52 weeks. The beta is 1.45, so CNTA's price volatility has been higher than the market average.

Beta (5Y)	1.45
52-Week Price Change	+107.25%
50-Day Moving Average	11.04
200-Day Moving Average	9.52
Relative Strength Index (RSI)	67.54
Average Volume (20 Days)	478,471

Short Selling Information

Short Interest	1.10M
Short Previous Month	1.38M
Short % of Shares Out	1.24%
Short % of Float	n/a
Short Ratio (days to cover)	3.35

Income Statement

In the last 12 months, CNTA had revenue of $6.85 million and -$157.35 million in losses. Loss per share was -$1.56.

Revenue	6.85M
Gross Profit	6.85M
Operating Income	-155.46M
Pretax Income	-163.67M
Net Income	-157.35M
EBITDA	-155.10M
EBIT	-155.46M
Loss Per Share	-$1.56

Full Income Statement

Balance Sheet

The company has $294.83 million in cash and $85.65 million in debt, giving a net cash position of $209.19 million or $1.85 per share.

Cash & Cash Equivalents	294.83M
Total Debt	85.65M
Net Cash	209.19M
Net Cash Per Share	$1.85
Equity (Book Value)	286.97M
Book Value Per Share	2.54
Working Capital	328.75M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$146.31 million and capital expenditures -$71,000, giving a free cash flow of -$146.38 million.

Operating Cash Flow	-146.31M
Capital Expenditures	-71,000
Free Cash Flow	-146.38M
FCF Per Share	-$1.29

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-2,268.45%
Pretax Margin	-2,303.27%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-2,186.94%

Dividends & Yields

CNTA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.57%
Shareholder Yield	-6.57%
Earnings Yield	-9.71%
FCF Yield	-9.03%

Analyst Forecast

The average price target for CNTA is $12.75, which is -10.84% lower than the current price. The consensus rating is "Buy".

Price Target	$12.75
Price Target Difference	-10.84%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	96.21%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CNTA has an Altman Z-Score of 1.17 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.17
Piotroski F-Score	2